帕金森病中远程认知补救疗法的有效性和可行性:随机对照试验
Lisa Hoffman1, Nicholas D Burt2, Nicholas R Piniella2
1Department of Family Medicine, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Parkinson's disease
|June 12, 2023
概括
远程认知补救疗法 (CRT) 可能减缓帕金森病 (PD) 患者的认知衰退. 这项试点研究发现CRT是可行的和愉快的,这表明对PD患者的生活质量和日常功能有潜在的益处.
科学领域:
- 神经学 神经学
- 神经康复疗法 神经康复疗法
- 老年学是一门学科.
背景情况:
- 非运动症状,特别是认知障碍,显著影响帕金森病患者的生活质量和日常功能.
- 目前的药理疗法对这些症状的疗效有限.
- 诸如认知补救疗法 (CRT) 和体育炼等非药物干预措施在改善PD患者的认知功能和幸福感方面表现有前途.
研究的目的:
- 评估远程CRT程序对认知功能和生活质量的可行性和影响.
- 为了评估远程CRT的有效性,在一个有组织的PD患者团体炼计划的背景下.
主要方法:
- 一项随机对照试点研究,涉及24名PD患者参加了团体炼计划 (Rock Steady Boxing).
- 参与者被随机分配到对照组或干预组.
- 干预组每周两次接受10周的在线CRT,包括认知练习和小组讨论.
主要成果:
- 21名参与者完成了这项研究.
- 对照组显示了整体认知表现下降的趋势,延迟记忆和自我报告认知显著下降.
- 干预组没有经历这些下降,并报告了享受和主观改善.
结论:
- 远程CRT对于PD患者来说是一种可行的和愉快的干预措施.
- 这种方法可能有助于缓解帕金森病的认知衰退进展.
- 需要进一步的研究来证实远程CRT在PD管理中的长期影响.
更多相关视频
08:18A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
Published on: December 26, 2015
17.4K
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
401
相关概念视频
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:15Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611